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Purpose: The purpose of  this study was to evaluate the stenosis-free patency of  open 
repair (vein-patch angioplasty, interposition, jump grafting) and percutaneous translu- 
minal balloon angioplasty (PTA) of  144 vein graft stenoses that were detected uring 
duplex scan surveillance after infrainguinal vein bypass grafting. 
Methods: Patients who underwent revision of  an infrainguinal vein bypass graft were ana- 
lyzed for type of  vein conduit, vascular laboratory findings leading to revision, repair 
techniques, assisted graft patency rate, procedure mortality rate, and restenosis of  the 
repair site. 
Results: The time of  postoperative r vision ranged from 1 day to 133 months (mean, 13 
months). One hundred eighteen primary and 26 recurrent stenoses (peak systolic veloc- 
ity, >300 cm/s) in 52 tibial and 35 popliteal vein bypass grafts were identified by means 
of  duplex scanning. The repairs consisted of  77 open procedures (vein-patch angioplas- 
ty, 28; vein interposition, 33; jump graft, 9; primary repair, 3) and 67 PTAs. No patient 
died as a result of  intervention. Cumulative assisted graft patency rate (life-table analy- 
sis) was 91% at 1 year and 80% at 3 years. At 2 years, cumulative assisted graft patency 
rate was comparable for saphenous vein grafts (reversed, 94%; in situ, 88%; nonreversed, 
63%) and alternative vein grafts (89%). Stenosis-free patency rate at 2 years was identi- 
cal (P = .55) for surgical intervention (63%) and endovascular intervention (63%) but 
varied with type of  surgical revision (P = .04) and time of  intervention (<4 months, 45%; 
>4 months, 71%; P = .006). The use of  duplex scan-monitored PTA to treat focal 
stenoses (<2 cm) and late-appearing stenoses (>3 months) was associated with a steno- 
sis-free patency rate that was 89% at 1 year. After intervention, the alternative vein 
bypass grafts necessitated twice the reinterventions per month of  graft survival (P = .01). 
Bypass graft to the popliteal versus infrageniculate arteries, site of  graft stenosis (vein 
conduit, anastomotic region), and repair of  a primary versus a recurrent stenosis did not 
influence the outcome after intervention. 
Conclusion: The revision of  duplex scan-detected vein graft stenosis with surgical or 
endovascular techniques was associated with an excellent patency rate, including when 
intervention on alternative vein conduits or treatment of  restenosis was necessary. When 
PTA was selected on the basis of  clinical and duplex scan selection criteria, the endovas- 
cular treatment of  focal vein graft stenosis was effective, durable, and comparable with 
the surgical revision of  more extensive lesions. (J Vasc Surg 1999;29:60-71.) 
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The vascular laboratory surveillance o f  infrain- 
guinal vein bypass grafts to detect stenosis from inti- 
real hyperplasia, fibrous stricture, or atherosclerosis 
has become a practice standard. >4 The strategy of  
postoperative surveillance is used not only to detect 
the failing graft but also to assist he surgeon in decid- 
ing when to intervene and what type of  intervention 
to choose to correct the graft abnormality. No  con- 
sensus exists regarding the "best" secondary proce- 
dure for postimplantation stenotic lesions. The repair 
technique and the outcome of  graft revision depend 
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on a number of factors including the following: the 
length of stenosis, the location (anastomosis, venous 
conduit, adjacent native artery), the type of vein con- 
duit, the time of occurrence, and the precision of the 
repair itself. Surgical repairs, such as vein-patch angio- 
plasty, interposition grafting, and jump grafting, are 
preferred on the basis of the low morbidity of inter- 
vention, the high early patency rate, and a long-term 
assisted graft patency rate in excess of 80%.1, 5-7 By 
comparison, the use of percutaneous transluminal 
angioplasty (PTA) to correct vein graft stenosis is 
more controversial. The applicability and durability of 
PTA have been questioned by some vascular groups 
who do not recommend its use, yet other groups have 
reported success rates in excess of 80%. 8-1° No study 
has compared surgical management with endovascu- 
lar management of vein graft stenoses in terms of graft 
types, assisted graft patency rates, or the need for rein- 
tervention. In this retrospective r view, the morbidity 
rate and the stenosis-free patency rate of open surgi- 
cal repair were compared with endovascular ngio- 
plasty in the management of 118 primary and 26 
recurrent vein graft stenoses in 87 infrainguinal vein 
bypass grafts that were detected with duplex scan sur- 
veillance and repaired with techniques selected on the 
basis of the clinical and duplex ultrasound scan fca- 
narcs of each stcnosis. 
MATERIAL AND METHODS 
Study populat ion.  Patients who underwent 
revision of an infrainguinal vein bypass graft from 
1992 to February 1998 were identified through the 
vascular egistries of the University of South Florida 
Division of Vascular Surgery and the ]A Haley 
Veterans Affairs Hospital. During this time interval, 
528 infrainguinal vein bypass grafting procedures 
were performed. In 84 patients (87 bypass grafts), 
118 primary sites of stenosis were detected and sub- 
jected to repair. The vascular laboratory, hospital, 
and outpatient clinic records were reviewed, and the 
data were tabulated for type of vein bypass graft con- 
duit, duplex scan findings leading to revision, repair 
techniques, assisted graft patency rate, restenosis of 
the repair site, and procedure mortality rate. Patients 
with hemodynamic vein graft failure caused by prox- 
imal prosthetic limb occlusion (n = 1 ) and vein graft 
occlusions (n = 2) that were not successfully opened 
with catheter-directed thrombolysis or salvaged with 
thrombolysis alone were not included. The mean 
follow-up time after graft revision was 17 months. 
Four patients were lost to follow-up beyond 6 
months of graft revision. 
The study group consisted of 87 grafts in 59 
men and 25 women (mean age, 66 years; range, 31 
to 84 years). Fifty-three grafts underwent a single 
revision, and 34 grafts had multiple revisions for 
metachronous or recurrent graft stenosis. The indi- 
cations for bypass grafting in the 87 lower limbs 
included critical ischemia manifested as rest pain, 
ulceration, or gangrene in 79 limbs, claudication i  
6 limbs, and asymptomatic popliteal aneurysm in 2 
limbs. Bypass grafting techniques used at the prima- 
ry procedure included the following: in situ saphe- 
nous vein bypass (n = 30), reversed saphenous vein 
bypass (n = 19), nonreversed translocated saphenous 
vein bypass (n = 16), and alternative vein bypass (n 
= 22). The average time from bypass grafting proce- 
dure to the first or "primary" graft revision proce- 
dure was 13 months (range, 1 day to 133 months). 
A total of 144 interventions were performed on 50 
femorotibial, 35 femoropopliteal, and 2 popliteal- 
pedal vein bypass grafts to correct 94 initial graft 
stenoses, 24 metachronous lesions, which developed 
at another site during the follow-up period, and 26 
restenoses after intervention. 
Vascular laboratory testing. Infrainguinal vein 
bypass abnormalities were identified with a postoper- 
ative surveillance program that included clinical eval- 
uation, Doppler scan-derived limb pressure measure- 
ments, and color duplex scanning. In general, the 
graft surveillance was performed before discharge, at 
4 to 5 weeks after surgery, and at 3-month or 6- 
month intervals thereafter on the basis of vein bypass 
graft type and the presence or absence of a duplex 
scan-detected bypass graft abnormality. Beyond 2 
years after operation or revision, annual graft surveil- 
lance was performed if the prior duplex scan results 
were normal and if atherosclerotic disease risk factors 
(hypertension, serum cholesterol level, and tobacco 
use) were under control. At each postoperative evalu- 
ation, the entire vein graft, including both anasto- 
moses and adjacent native artery, was visualized and 
the measurements of peak systolic blood flow velocity 
(PSV) were recorded at several sample sites along the 
bypass graft and in the anastomotic regions. If color 
Doppler imaging identified a stenosis, the measure- 
ments of PSV at the stenosis and the PSV velocity 
ratio (Vr), where Vr = PSVat lesion/PSV proximal, were 
recorded and the lesions with PSV more than 300 
cm/s or velocity ratio more than 3.5 were selected for 
repair. The lesions that were identified with serial 
duplex scans to progress in stenosis everity or that 
were associated with the development of low graft 
flow velocity (<45 cm/s) were recommended for 
repair. Angiography was performed before interven- 
tion on a selective basis--when duplex scan-detected 
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stenoses were selected for PTA and to evaluate long- 
segment or multiple graft lesions, particularly if 
lesions in the inflow or outflow native arteries were 
also detected. Twenty-four of the 77 surgical revisions 
(31%) were performed on the basis of duplex scan 
findings alone. 
Techniques of  vein bypass graft revision. 
Open surgical and endovascular techniques that 
were used to repair stenotic bypass graft segments 
varied with anatomic site, lesion length, conduit 
diameter, and appearance time from the primary 
grafting procedure. In general, vein-patch angioplas- 
ty or PTA was used to treat focal (<4 cm) postim- 
plantation lesions (myointimal hyperplasia, vein 
fibrous, sclerotic valves). More extensive longer 
lesions, such as sclerotic vein segments, multiple 
graft stenoses, and diffuse myointimal or atheroscle- 
rotic lesions that involved perianastomotic inflow or 
runoff arteries, were treated with interposition or 
"jump graft" techniques. Operative techniques of 
open surgical repair, including the use of intraoper- 
ative duplex scanning of the repair site to exclude 
residual stenosis, have been previously detailed. 7 
On the basis of clinical outcomes gleaned in the 
past 10 years, we have found the appearance time of 
a graft stenosis to be an important criterion for the 
selection of PTA. Lesions that are identified in the 
early postoperative period are related to poor quali- 
ty vein or procedure problems (vein torsion, graft 
entrapment) and necessitate surgical attention. 
Lesions that develop into high-grade stenoses 
beyond 3 months after the primary procedure are 
selected for endovascular treatment if the lesion fea- 
tures are those of focal (<2 cm in length) stenosis 
and if the vein bypass graft has a good caliber (>3.5 
mm). In selected patients, early PTA has been per- 
formed to correct a native inflow artery stenosis or 
used when surgical intervention was not possible 
because of the patient's medical condition or wishes. 
During the past 2 years, duplex scan monitoring of 
the PTA procedure was performed to ensure the 
normalization of the PTA site hemodynamics (PSV, 
<180 cm/s; Vr, <2.0) within the graft segment sub- 
jected to balloon dilation. 
The patients who were recommended to under- 
go vein graft PTA were treated as outpatients and 
lodged in a 23-hour observation unit. After a prein- 
tervention angiography to confirm the appropriate 
anatomic features of a stenosis uitable for PTA, the 
patients were administered systemic heparin to pro- 
long the activated clotting time of more than 250 
seconds and balloon dilation of the stenotic vein 
conduit or native artery segment was performed. 
The initial balloon diameter size was chosen on the 
basis of  preintervention duplex scan findings. In 
general, the inflation pressures and times were in the 
range of 8 to 12 atm and 45 seconds to 1 minute in 
duration. If duplex scan monitoring of the PTA site 
identified residual stenosis (PSV, >180 cm/s;  Vr, 
>2.0), repeat transluminal dilation was performed 
with either prolonged inflation time (2 to 3 min- 
utes) or a larger (1 to 2 mm) balloon. 
Data analysis. Estimations of cumulative assist- 
ed graft patency rate and stenosis-free patency rate 
(ie, graft was patent and no intervention for recur- 
rent stenosis was performed) were performed with 
the Kaplan-Meier life-table method beginning at the 
time of graft revision. Statistical analysis was per- 
formed and compared the outcome of surgical ver- 
sus endovascular (PTA) intervention on both prima- 
ry and recurrent stenosis and the time to interven- 
tion, bypass graft type, and surgical repair technique. 
The differences in life-table patency rate were ana- 
lyzed with the log-rank test, with a P value of less 
than .05 considered significant. A comparison of 
graft revision frequency relative to type of vein con- 
duit was performed with the likelihood ratio test on 
the basis of the Poisson distribution. 
RESULTS 
The site and clinical features of the 118 sites of 
primary stenosis and the 26 sites of restenosis are 
detailed in Table I. One quarter of the patients had 
symptoms of limb ischemia (claudication, i6; ulcer- 
ation, 10; rest pain, 6) at the time of graft revision. 
On the basis ofhistologic examination and operative 
findings, the most common graft lesion was myoin- 
ritual hyperplasia, with the predominant location in 
the vein conduit or at the distal anastomotic region. 
M1 the submitted explanted graft specimens (n = 34) 
showed wall thickening with varying degrees of cel- 
lularity and the histology of myointimal hyperplasia. 
In general, the graft abnormalities that were repaired 
within 1 month were not submitted because these 
early lesions represented residual defects caused by 
technical error (incomplete valve lysis, graft torsion) 
or intrinsic vein conduit abnormality (sclerosis, small 
diameter). Metachronous graft stenosis developed in 
24 bypass grafts at a mean of 4.2 months after inter- 
vention for a stenosis at another site. One half of the 
alternative vein bypass grafts developed multiple 
sites of stenosis. At 20 sites at which a primary graft 
stenosis developed, the intraoperative or predis- 
charge duplex scan had shown a mild (PSV, 150 to 
230 cm/s) residual stenosis. The sites of stenoses 
that were revised within the 4 months of operation 
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Fig 1. Number of surgical and endovascular (percutaneous transluminal balloon angioplasty) 
interventions for 118 primary (A) and 26 recurrent (B) vein graft stenoses relative to postin- 
tervention time interval. 
PTA, Percutaneous transluminal ngioplasty. 
showed decreased stenosis-free patency rates at 2 
years (<4 months, 45%; >4 months, 71%; P = .006). 
Intervention at 144 sites of primary and recur- 
rent stenosis consisted of 67 PTAs and 77 open sur- 
gical repairs, including vein-patch angioplasty (n = 
33), interposition graft (n = 30), jump graft (n = 
11), and primary repair (n = 3). Stenosis everity on 
the basis of duplex scan peak velocity criteria was 
similar for the lesions that were treated surgically 
(373 _+ 45 cm/s) and with PTA (368 + 42 cm/s). 
Nonfocal stenosis (length, >2 cm) was more com- 
monly treated with surgery (27 of 77 [35%]) than 
with PTA (5 of 67 [7%]). Twice the number of 
patients who underwent surgical revision were 
symptomatic as compared with the patients who 
underwent PTA. The frequency of surgical and 
endovascular repair of primary and recurrent graft 
stenosis relative to the postoperative time interval is 
shown in Fig 1. Surgical repair was used more fre- 
quently for early-appearing (<4 months) primary 
lesions (30 of 37 interventions [81%]) after bypass 
grafting, and PTA was the most common method of 
stenosis repair beyond 4 months (49 of 81 interven- 
tions [60%]). Of the 7 surgical revisions that were 
performed within 1 Week of the operation, two 
grafts remained patent, four necessitated subsequent 
reintervention for stenosis, and one was occluded. 
Overall, three quarters of the revisions (92 of 118) 
for primary graft stenosis were performed within the 
first postoperative y ar. In the 87 grafts, a total of 
144 secondary procedures were performed (average, 
1.7 interventions/graft; range, 1 to 6 revisions). 
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Fig 2. Limb salvage rates and cumulative-assisted graft patency rates (life-table method) of 87 
grafts revised for duplex scan-detected stenosis (peak systolic blood flow velocity, >300 cm/s; 
velocity ratio, >3.5). 
Table I. Site and clinical characteristics of 118 pri' 
mary stenoses and 26 recurrent stenoses revised in 
87 infrainguinal vein bypass grafts 
Primary Recurrent 
stenosis stenosis 
Site of stenosis 
Proximal anastomotic region 24 6 
Vein conduit 48 11 
Distal anastomotic region 46 9 
Type of bypass graft 
Femoropopliteal (n = 35) 45 13 
Femorotibial (n = 50) 71 13 
Popliteal-pedal (n = 2) 2 0 
Bypass grafting technique 
In situ saphenous vein (n = 30) 37 9 
Reversed saphenous vein (n = 19) 27 8 
Nonreversed, translocated saphenous 22 6 
(n = 16) 
Alternative or spliced (n = 22) 32 3 
Postoperative time to intervention 
<4 months 37 13 
>4 months 81 13 
Surgical repair and PTA were applied with equal fre- 
quency in revision of the various types of saphenous 
and alternative vein bypass grafts (Table II). At the 
118 sites of primary stenosis, 96 sites necessitated a 
single revision, 19 necessitated 2 interventions, 2 
necessitated 3 revisions, and 1 necessitated 4 inter- 
ventions. MI the grafts that necessitated more than 
one revision remained patent, and no limb loss 
Table II. Type of intervention for 144 graft 
stenoses relative to bypass graft type 
Surgery PTA 
Bypass graft type 
In sire saphenous 25 21 
Reversed saphenous 21 14 
Nonreversed translocated saphenous 14 14 
Alternative vein 17 18 
PTA, Percutaneous transluminal balloon dilation. 
occurred in this patient cohort. Overall, the limb sal- 
vage rate was 96% at 1 year and 90% at 3 years (Fig 
2). Five below-knee amputations were performed 
after graft failure, including one in a patient with 
diabetes with end-stage renal failure and failure of a 
transmetatarsal amputation to heal despite a patent 
popliteal-pedal bypass grafting procedure. 
No patient died as a result of intervention. Nine 
patients died during the mean follow-up interval of 
17 months, which resulted in a patient survival rate of 
89%. The cumulated assisted graft patency rate after 
revision was 91% at i year, 84% at 2 years, and 79% at 
3 years (Fig 2) and at 2 years was comparable (P = 
.26) for saphenous (in situ, 88%; reversed, 94%; non- 
reversed, 63%) and alternative (89%) vein grafts. Ten 
graft failures occurred (mean time to occlusion of 9 
months after revision)--six were caused by multiple 
segmental stenosis in a small diameter vein conduit, 
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Fig 3. Stenosis-free patency rate (endpoint of graft occlusion and intervention for restenosis) 
for surgical and endovascular (percutaneous translurninal balloon angioplasty) repair of 118 
sites of primary stenosis in 87 grafts. 
PTA, Percutaneous transluminal ngioplasty. 
Table I I I .  Number of restenoses repaired and graft occlusions following surgical and endovascular inter- 
vention for primary (n = 118) graft stenosis 
No. of primary stenoses repaired No. of secondary stenoses repaired* No. of graft occlusions 
Type of surgical repair 
Vein-patch angioplasty 25 8 2 
Interposition graft 25 5 4 
Jump/sequential bypass graft 9 2 2 
Primary repair 3 0 0 
Endovascular repair 
PTA 36 5 0 
Duplex scan-monitored PTA 20 6 2 
Total 118 26 10 
UFA, Percutaneous transluminal ngioplasty. 
Selection criteria: stenosis, <2 cm; vein diameter, >3.5 mm; appearance time, >3 months after primary procedure or intervention for graft 
stenosis. 
*Restenosis at site of prior surgical repair or percutaneous transluminal ngioplasty. 
two from repair site failure, and two from progression 
of  outflow tract atherosclerotic disease (Table III). 
Five redo bypass grafting procedures were performed 
for critical ischemia. The incidence rate of graft occlu- 
sion and the need for reintervention for restenosis (ie, 
stenosis-free patency) were similar (P= .55) at 2 years 
after surgical (63%) or endovascular (63%) interven- 
tion (Table IV; Fig 3). In the treatment of focal graft 
stenosis, the 1-year stenosis-free patency rate of  PTA 
(n = 56) was 66% and comparable with the 76% steno- 
sis-free patency rate of vein-patch angioplasty (n = 25; 
Table III; Appendix). No difference in outcome was 
observed in the treatment of primary sites of stenosis 
versus restenosis after intervention. The stenosis-free 
patency rate at 2 years was 63% for primary lesions 
and 79% for restenoses (P = .2; Fig 4). Alternative 
vein bypass grafts necessitated twice the reinterven- 
tions per month of graft survival as compared with in 
situ or reversed saphenous vein grafts (P = .01), and 
only two alternative vein grafts failed. The revisions of 
infrageniculate bypass grafts were as successful as with 
the popliteal bypass grafts (P = .86), and the site of 
graft stenosis (vein conduit versus anastomotic 
region) did not influence outcome after the interven- 
tion (P = .77). The secondary revisions for restenosis 
(n = 26) were successful with an equivalent stenosis- 
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Fig 4. Stenosis-free patency rate of graft revision for primary (n = 118) or recurrent (n = 26) 
graft stenosis. 
P value = .2, with log-rank test. 
Table IV. Crude patency rates and stenosis-free patency rates (life-table method)  after surgical or endovas- 
cular repair o f  118 sites o f  pr imary graft stenosis 
Cumulative 1-year* Assisted 2-yeart 
Crude patency rate (%) patency rate (%) patency rate (%) P value 
Type of intervention 
PTA (n = 56) 65 66 63 .55 
Surgery (n = 62) 69 69 63 .55 
Vein-patch angioplasty (n = 22) 82 76 76 .04 
Interposition graft (n = 23) 57 47 47 
Jump graft (n = 10) 82 88 58 
Primary repair (n = 3) 100 
Time of intervention 
<4 months (n = 36) 53 51 45 .006 
>4 months (n = 80) 75 74 71 
Bypass graft outflow artery 
Popliteal (n = 45) 67 66 58 
Tibial/pedal (n = 71) 69 68 68 .86 
Site of stenosis 
PAG (n = 24) 71 70 6i .77 
Vein conduit (n = 47) 72 67 67 .77 
DAG (n = 44) 61 64 59 .77 
PAG, Proximal anastomotic graft region; DAG, distal 
*Life-table analysis, tandard error less than 7%. 
-[Life-table analysis, tandard error less than 10%. 
anastomotic graft region including outflow artery. 
free patency rate for PTA (9 o f  11; 82%) and surgery 
(13 of  15; 87%). No  graft that was revised for recur- 
rent stenosis failed during the follow-up interval. 
Beginning in 1996, vein graft PTA procedures 
were per fo rmed with duplex scan mon i to r ing  to 
detect  residual stenosis. Twenty-s ix  pat ients have 
undergone duplex scan-mon i tored  PTA,  which 
accounts for 75% of  the PTA procedures dur ing this 
t ime interval.  In  21 o f  the 26 procedures ,  the 
anatomic and clinical criteria (appearance t ime, >3 
months;  stenosis length, <2 cm; vein diameter, >3.5 
mm) for use o f  PTA were met  and 19 o f  the 21 sites 
remained patent (90%) at 1 year. The 1-year steno- 
sis-free patency rate in this group o f  pat ients was 
89% as compared with 61% (P = .03) in the remain- 
ing PTA procedures. Duplex scan evaluation identi-  
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F ig  5. Evaluation algorithm of vein graft percutaneous transluminal balloon angioplasty with 
arteriography and duplex ultrasound scanning. 
PTA, Percutaneous transluminal ngioplasty; PSV, peak systolic blood flow velocity; Vr, veloc- 
ity ratio. 
fled residual stenosis during nine PTA procedures, 
which prompted reintervention with a larger balloon 
(n = 5) or a prolonged inflation time (n = 4). Eight 
of these PTA sites remained free of stenosis during 
the follow-up interval (mean, 9 months), and one 
site restenosed at 5 months and underwent a second 
PTA successfully. 
DISCUSSION 
This study confirms the findings of o~h~r vascu- 
lar groups concerning the excellent assl,~ted graft 
patency rates of infrainguinal vein bypass grafts that 
are subjected to revision while patent to repair a 
duplex scan-detected graft stenosis. The assisted 
graft patency rate of 80% at 3 years was similar to 
that of a prior report that dealt with revision of in 
situ saphenous vein arterial bypass grafts (89% at 3 
years). 11 The important differences with the present 
study were the expanded application of  PTA to 
dilate focal graft lesions and the intervention on 
bypass grafts of various types, including alternative 
vein bypass grafts. When PTA was applied selective- 
ly, the outcome as measured with stenosis-free 
patency rate was similar to open surgical repair (63% 
versus 63% at 2 years; life-table analysis). Although 
the reintervention rate after PTA (22%) was higher 
than after surgical revision (14%), fewer graft failures 
occurred (2 versus 8), which accounted for the iden- 
tical stcnosis-free patency rate. The lesions that were 
treated with open repair versus PTA did differ both 
in appearance time and in extent of lesion, with PTA 
used in selected patients with focal lesions. Other 
important findings of  this study included the similar 
outcome of  surgical or endovascular intervention 
regardless of  the graft type, treatment of  primary 
versus recurrent stenosis, and site of graft stenosis. 
The clinical relevance of these observations involves 
the use of  anatomic features and appearance time of 
stenosis as the major criteria for recommending 
open surgical repair or PTA. This approach, when 
combined with continued uplex scan surveillance, 
was effective in maintaining raft patency. The graft 
failure rate was 11%, with the predominant causes 
being development of  diffuse/multiple vein graft 
strictures or atherosclerotic disease progression ot 
amenable to surgical or endovascular intervention. 
Nehler et al7 reported a 96% assisted graft patency 
rate after the exclusively surgical revision of reversed 
vein bypass grafts but included in the analysis the 
treatment of inflow and outflow occlusions, lesions 
associated with low risk of failure after bypass graft- 
ing. Our study data indicate that the success of inter- 
vention for vein graft stenosis caused by myointimal 
hyperplasia or fibrous stricture may be more depen- 
dent on the technical precision of the repair proce- 
dure and the pathobiology at the site that produced 
progressive lumen reduction. Early lesions have been 
shown to be more biologically active and thus may 
be more prone to recurrence arly after surgical 
intervention and may not be suited for treatment 
with PTA. 12 
We believe that the use of  duplex scan criteria for 
PTA application is important for a successful out- 
come. This includes the treatment of focal lesions in 
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good caliber vein conduits beyond the early postop- 
erative period of graft arterialization and the moni- 
toting of the PTA procedure with duplex scanning to 
detect and treat residual stenosis. Our initial experi- 
ence with duplex scan-monitored PTA of vein graft 
stenoses indicates that this type of surveillance is use- 
ful because a residual stenosis was identified in 9 of 
the 26 procedures despite angiogram results that 
indicated asuccessfial intervention. Further PTA with 
either a prolonged inflation time or a 1-mm to 2-mm 
larger balloon normalized the PTA site hemodynam- 
ics, criteria that we have previously documented tobe 
important for angioplasty site. In the treatment algo- 
rithm that is shown in Fig 5, duplex scan assessment 
that is performed after angiography confirms a wide- 
ly patent bypass graft, no complication (vein rupture, 
distal embolization), and a less than 30% diameter 
reduction in residual stenosis. On occasion, it is pru- 
dent to accept a residual duplex scan-detected steno- 
sis after PTA to avoid vein injury (ie, rupture) and 
then, if stenosis everity recurs, proceed with surgical 
intervention. 
With the application of vascular laboratory graft 
surveillance, most of the patients with failing grafts 
now are identified earlier, typically while asympto- 
marie, and are associated with modest decreases (0.1 
to 0.3) in ankle-brachial systolic pressure index as 
compared with initial postoperative alues. A recent 
meta-analysis of  infrainguinal bypass grafts with 
postoperative surveillance concluded that graft 
patency rate is improved but enhanced limb salvage 
rate (ie, reduction in amputations) has not been 
shown. 6Although graft stenosis and other anatomic 
abnormalities can be accurately identified with 
duplex scanning, which grafts are at the highest risk 
for thrombosis and, therefore, should be revised is 
less clear. The cost of postoperative surveillance in 
terms of time and health care dollars is significant, 
but most surgeons, and certainly the patients them- 
selves, feel that the detection of the failing graft 
before thrombosis is worthwhile. This study con- 
firmed that the bypass grafts that were constructed 
with alternative veins are at the highest risk for 
developing a metachronous stenosis and that rein- 
tervention rates were twice as high as those observed 
after in situ or reversed saphenous vein bypass graft 
revision. 
Duplex scan surveillance of infrainguinal vein 
bypass grafts that Use the combination of high-veloc- 
ity and low-velocity criteria identifies the grafts with 
a low flow and a pressure-reducing stenosis. The 
duplex scan features of stenosis include the presence 
of a "flow jet" in systole and visualized lumen reduc- 
tion. Velocity criteria include increased velocities in 
both systole (>300 cm/s) and diastole (>75 to 100 
cm/s) and peak systolic velocity ratios across the 
stenosis more than 3.4. Low graft flow criteria 
include velocities more than 45 cm/s in normal (no 
stenosis, diameter 5 mm or less) grafts, particularly if 
no diastolic flow is identified. In a prospective study, 
the application of these threshold criteria identified 
all the grafts at risk for thrombosis and only one 
lesion with these velocity criteria regressed. 14We 
agree with recent reports that duplex scan results can 
be used without confirmatory arteriography to rec- 
ommend graft revision to the patient who is asymp- 
tomatic. 15 Approximately one third of all the surgi- 
cal revisions were performed on the basis of duplex 
scan findings alone, and all the patients who were 
selected for PTA underwent the planned endovascu- 
lar procedure. 
The goal of surveillance is not only to detect he 
failing graft but also to assist he surgeon in the deci- 
sion of when to intervene and of which procedure 
would best correct the abnormality. The surgical 
options of vein-patch angioplasty, interposition graft- 
ing, and jump grafting have become the standard 
approach to repair of vein graft stenosis, and the 
application of PTA for graft revision is more contro- 
versial. In the current series, angioplasty was applied 
to stenoses in the venous conduit, at anastomotic 
sites, and at diseased outflow. Nearly half of all the 
vein bypass graft stenoses that were identified were 
managed with balloon dilation PTA. By contrast, in a 
previously published series by Bandyk et al, 1 only 
17% of the stenoses were managed with PTA and 
applied to the venous conduit in only 5 cases. In 
another previous report, we identified clinical and 
anatomic duplex scan features that predict PTA suc- 
cess. 3 The criteria include stenosis everity, length of 
lesion, vein size, and appearance time (eg, peak veloc- 
ity, >300 cm/s; Vr, >3.4; vein size, >3.5 mm; steno- 
sis length, <2 cm; appearance time, >3 months after 
bypass grafting). On the basis of these results, we 
modified our management of vein graft stenosis uch 
that the lesions with this criteria are managed with 
PTA. Working in concert with our interventional vas- 
cular radiologist colleagues, we have used duplex 
scanning during the PTA procedure to monitor the 
hemodynamic result of dilation. In a significant num- 
ber of cases, 9 of 26 (34%), the procedure was mod- 
ified entirely on the basis of the duplex scan findings. 
Additional endovascular t eatment of the stenosed 
vein segment with either a larger balloon or a pro- 
longed inflation time, improved velocity spectra, and 
a low incidence rate ofrestenosis (90% at 1 year) was 
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observed. The Montefiore group 16 reported a 66% 
2-year graft patency rate after vein graft PTA when 
arteriography identified a concentric, short (<15 
mm) stenosis in an otherwise normal vein bypass 
graft and treatment produced a normal angiographic 
appearance. This group observed poor results (17% 
patency rate) in treating the more complex lesions 
(multiple stenoses, recurrent lesion, small diameter 
vein). Direct surgical repair or vein graft replacement 
is recommended for the lesions that do not meet our 
duplex scan selection criteria (ie, early-appearing or 
long-segment stenosis and focal stenosis in small cal- 
iber vein conduits ) . 
CONCLUSION 
Revision of  duplex scan-detected vein graft 
stenosis was associated with an excellent patency 
rate, including when the intervention on alternative 
vein conduits or the treatment of  restenosis was 
necessitated. Color duplex scanning has an estab- 
lished role in the detection and surveillance of  the 
failing infrainguinal bypass graft and has shown 
promise in stratifying lesions that are best treated 
with open (surgical) versus percutaneous balloon 
dilation. Approximately one third of  the surgical 
revisions were undertaken on the basis of duplex 
scan findings alone. When PTA was used in con- 
junction with clinical (>3 months after surgery) and 
duplex selection criteria (<2 cm stenosis in >3.5-mm 
diameter vein conduit), endovascular treatment of 
focal vein graft stenosis was effective, durable, and 
comparable with a surgical revision of more exten- 
sive lesions. 
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APPENDIX .  L IFE -TABLE ANALYS IS  OF  CUMULATIVE  STENOSIS -FREE PATENCY OF  118 
PR IMARY GRAFT STENOSES RELAT IVE  TO SURGICAL  REPAIR  (N  = 62)  OR PERCUTA-  
NEOUS TRANSLUMINAL  BALLOON ANGIOPLASTY (N  = 56)  AND ANALYS IS  OF  26  SEC-  
ONDARY REVIS IONS 
No. sitesfailing 
No. grafts Interval Cumulative Standard 
Interval (mo) No. sites at risk Restenosis Occlusion withdrawn* patency patency error (%) 
Surgery 
0 to 1 62 0 0 0 1.0 1.0 
1 to 3 62 3 2 3 0.92 1.0 
3 to 6 54 3 4 4 0.87 0.92 3.5 
6 to 12 43 4 1 8 0.88 0.79 5.3 
12 to 18 30 0 1 10 0.97 0.69 6.3 
18 to 24 19 1 0 4 0.95 0.66 6.6 
24 to 30 14 0 0 2 1.0 0.63 7.3 
30 to 36 12 0 0 2 1.0 0.63 7.3 
36 to 42 10 0 0 4 1.0 0.63 7.3 
42 to 48 6 0 0 2 1.0 0.63 7.3 
PTA 
0 to 1 56 0 1 0 0.98 1.0 
1 to 3 55 9 0 0 0.82 0.98 1.8 
3 to 6 46 4 0 3 0.89 0.82 5.1 
6 to 12 39 4 0 8 0.90 0.75 5.8 
12 to 18 27 1 0 11 0.96 0.66 6.6 
18 to 24 15 0 0 5 1.0 0.63 6.9 
24 to 30 10 0 1 7 0.90 0.63 6.9 
30 to 36 2 0 0 1 1.0 0.53 10.7 
Revision for recurrent stcnosis 
0 26 0 0 0 1.0 1.0 
1 to 3 26 2 0 2 0.92 1.0 
3 to 6 22 1 0 1 0.95 0.92 5.4 
6 to 12 20 2 0 9 0.90 0.88 6.7 
12 to 18 9 0 0 5 1.0 0.76 9.5 
18 to 24 4 0 0 0 1.0 0.76 9.5 
24 to 30 4 0 0 1 1.0 0.76 9.5 
30 to 36 3 0 0 0 1.0 0.76 9.5 
36 to 42 3 0 0 1 1.0 0.76 9.5 
*Reason for withdrawal of grafts was death or duration of follow-up interval 
D ISCUSSION 
Dr  Gary  F. Seabrook  (Milwaukee, Wis). This work by 
Dr Avino and his colleagues at the University of  South 
Florida represents another chapter in the manual that is 
now becoming a saga in the long-term care of  the lower 
extremity vein graft. Indeed, these conduits are dynamic 
structures that mature and, unfortunately, sometimes age 
prematurely. Careful surveillance allows the detection of  
pathologic events that will progress to graft failure. This 
manuscript advances the cause of  endovascular techniques 
in the salvage of  the threatened venous conduit. 
The authors conclude that the grafts that develop a 
focal stenosis after 3 months are likely to be successfully 
treated with percutaneous balloon angioplasty. Can you 
comment  on this arterialization process that seems to sta- 
bilize after 3 months,  and how that might  relate to the 
character of the lesions that develop in these mature grafts? 
A l though not  designed as a clinical trial, the report  
studies a similar number  of  lesions treated with endovas- 
cular techniques compared with those lesions treated with 
surgical approaches. Lesions were selected for endovascu- 
lar t reatment on the basis of  clinical prejudices that would 
portend a good result, and assisted graft patency in the 
series was similar to stenotic sites treated with direct oper- 
ative techniques. Interestingly, during the 6 years that data 
were accumulated,  87 conduits,  or 17% of  the grafts, 
necessitated revision. This compares with a 20% revision 
rate that our group identified and reported in 1990. The 
long- term patency rates in numerous,  large, r igorously 
control led series always are diminished by a group of  grafts 
that cannot be preserved espite a policy of  careful sur- 
veillance and aggressive intervention. We know that the 
need for modification of  a conduit  at the initial operation 
is a predictor of poor vein quality and of  twice the likeli- 
hood that secondary procedures will be necessary to main- 
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tain long-term patency. Did the grafts in your series neces- 
sitate modification, and are such veins included in the 
group described as "alternative bypass grafts"? The mes- 
sage here is that some veins are going to function poorly 
as arterial substitutes. 
Some focal stenoses that I have explored surgically 
look pretty ugly, not unlike the ulcerative lesions with 
intraplaque hemorrhage that we sometimes see at the focal 
stenosis of the internal carotid artery. Have you identified 
any duplex scan criteria that would preclude you from 
expanding a balloon across a lesion that might disintegrate 
and then embolize? Recognizing the rigorous scrutiny to 
which these authors subject their surgical results and the 
skepticism that I know they would apply to a controversial 
technique, the readers of the manuscript should consider 
the criteria presented here in selecting patients with focal 
graft stenosis for revision by percutaneous intervention. 
Dr Anthony J. Avino. Thank you, Dr Seabrook, for 
your comprehensive r view. 
Regarding the arterialization of the vein grafts, we 
believe that early-appearing lesions represent more of a 
biologically active process of myointimal hyperplasia with 
a higher rate of nuclear proliferation. This may be related 
to the arterialization process in the vein graft. We have 
found that lesions that develop in the first 3 months are 
more likely to recur if treated with balloon angioplasty ver- 
sus surgical revision. 
In regards to your second question, we did include 
grafts that were modified at operation. They were not clas- 
sified as "alternative vein grafts" on the basis of the need 
for intraoperative r vision unless the vein conduit was arm 
or spliced vein. On the basis of our experience with intra- 
operative duplex scanning, residual lesions that were iden- 
tified at the time of surgery and were corrected to a nor- 
mal duplex scan behaved the same as grafts that did not 
require intraoperative r vision. However, grafts that had a 
residual stenosis after intraoperative r vision, or those with 
a moderate stenosis that was accepted, were more prone to 
develop vein graft stenosis during the early (<3 months) 
postoperative p riod. These lesions were more likely to be 
treated surgically because they often appeared and pro- 
gressed to a high-grade stenosis in the first 3 months after 
operation. 
Dr Anthony M. Imparato (New York, NY). I enjoyed 
your paper. I am curious to know how you arrived at the cri- 
teria for the selection of the patients for balloon angioplasty? 
Dr Avino. Our vein graft revision criteria were derived 
from our experiences in the past 10 years, which were sim- 
ilar to those reported by the Montefiore group. We found 
that nonfocal lesions that were developed in the early post- 
operative period or in small caliber vein segments had a 
poor outcome when managed with balloon angioplasty. 
Dr Roger M. Hayashi (San Jose, Calif). Your group 
has always advocated aggressive duplex scan surveillance of 
grafts, yet despite your aggressive approach to follow-up, 
approximately 10% to 20% of your grafts will close occult- 
ly. You chose, as the basis of your surveillance criteria, a 
peak systolic ratio of  3.5 or a peak systolic velocity of 
greater than 300. Do you think your ability to detect some 
of these occult closures would be improved if you lowered 
your surveillance standards to levels advocated by others? 
Dr Avino. Ten graft failures occurred during surveil- 
lance-six were caused by multiple segmental stenosis in a 
small diameter vein conduit, two from repair site failure, 
and two from progression of outflow tract atherosclerotic 
disease. We believe we could slightly improve our occlu- 
sion rate by lowering the revision criteria but that this 
would result in a significantly greater number of revisions. 
Dr Jamal J. Hobal lah (Iowa City, Iowa). Do you 
believe that mid-graft stenoses and anastomotic orperianas- 
tomotic stenoses respond similarly to balloon angioplasty? 
Dr Avino. We found no differences in the success of 
angioplasty applied to lesions in the vein conduit versus 
the anastomosis a  long as the specific revision criteria 
were followed (focal stenosis in good caliber vein that 
developed greater than 3 months after surgery). 
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